Tolón RM - Search Results

1

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

Fernández-Ruiz J, Romero J, Velasco G, Tolón RM, Ramos JA, Guzmán M. Fernández-Ruiz J, et al. Among authors: tolon rm. Trends Pharmacol Sci. 2007 Jan;28(1):39-45. doi: 10.1016/j.tips.2006.11.001. Epub 2006 Dec 1. Trends Pharmacol Sci. 2007. PMID: 17141334 Review.

2

Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease.

Sagredo O, González S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, Romero JP, Tolón RM, Mechoulam R, Brouillet E, Romero J, Fernández-Ruiz J. Sagredo O, et al. Among authors: tolon rm. Glia. 2009 Aug 15;57(11):1154-67. doi: 10.1002/glia.20838. Glia. 2009. PMID: 19115380 Free PMC article.

3

Functional neuroanatomy of the endocannabinoid system.

Pazos MR, Núñez E, Benito C, Tolón RM, Romero J. Pazos MR, et al. Among authors: tolon rm. Pharmacol Biochem Behav. 2005 Jun;81(2):239-47. doi: 10.1016/j.pbb.2005.01.030. Pharmacol Biochem Behav. 2005. PMID: 15936805 Review.

4

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

Benito C, Romero JP, Tolón RM, Clemente D, Docagne F, Hillard CJ, Guaza C, Romero J. Benito C, et al. Among authors: tolon rm. J Neurosci. 2007 Feb 28;27(9):2396-402. doi: 10.1523/JNEUROSCI.4814-06.2007. J Neurosci. 2007. PMID: 17329437 Free PMC article.

5

The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages.

Tolón RM, Núñez E, Pazos MR, Benito C, Castillo AI, Martínez-Orgado JA, Romero J. Tolón RM, et al. Brain Res. 2009 Aug 4;1283:148-54. doi: 10.1016/j.brainres.2009.05.098. Epub 2009 Jun 6. Brain Res. 2009. PMID: 19505450

6

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.

Benito C, Núñez E, Tolón RM, Carrier EJ, Rábano A, Hillard CJ, Romero J. Benito C, et al. Among authors: tolon rm. J Neurosci. 2003 Dec 3;23(35):11136-41. doi: 10.1523/JNEUROSCI.23-35-11136.2003. J Neurosci. 2003. PMID: 14657172 Free PMC article.

7

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study.

Núñez E, Benito C, Pazos MR, Barbachano A, Fajardo O, González S, Tolón RM, Romero J. Núñez E, et al. Among authors: tolon rm. Synapse. 2004 Sep 15;53(4):208-13. doi: 10.1002/syn.20050. Synapse. 2004. PMID: 15266552

8

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.

Aymerich MS, Aso E, Abellanas MA, Tolon RM, Ramos JA, Ferrer I, Romero J, Fernández-Ruiz J. Aymerich MS, et al. Among authors: tolon rm. Biochem Pharmacol. 2018 Nov;157:67-84. doi: 10.1016/j.bcp.2018.08.016. Epub 2018 Aug 17. Biochem Pharmacol. 2018. PMID: 30121249 Free article. Review.

9

Cannabinoid CB2 receptors in human brain inflammation.

Benito C, Tolón RM, Pazos MR, Núñez E, Castillo AI, Romero J. Benito C, et al. Among authors: tolon rm. Br J Pharmacol. 2008 Jan;153(2):277-85. doi: 10.1038/sj.bjp.0707505. Epub 2007 Oct 15. Br J Pharmacol. 2008. PMID: 17934510 Free PMC article. Review.

10

Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance.

Gómez M, Hernández ML, Pazos MR, Tolón RM, Romero J, Fernández-Ruiz J. Gómez M, et al. Among authors: tolon rm. Neuroscience. 2008 May 15;153(3):687-99. doi: 10.1016/j.neuroscience.2008.02.038. Epub 2008 Feb 29. Neuroscience. 2008. PMID: 18400407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters